Opportunity Information: Apply for CDC RFA PS09 999
Apply for CDC RFA PS09 999
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Prevention of Cervical Cancer in HIV Positive Women in the Federal Democratic Republic of Ethiopia under the President s Emergency Plan for AIDS Relief" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 30, 2009 and posted on Mar 30, 2009.
- Applicants must submit their applications by May 28, 2009 Applications are due by 500pm Eastern on closing date. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,468,885.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $493,777.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity (Funding Opportunity Number CDC RFA PS09-999) is a Centers for Disease Control and Prevention (CDC) cooperative agreement focused on reducing cervical cancer risk among women living with HIV in the Federal Democratic Republic of Ethiopia, supported under the President's Emergency Plan for AIDS Relief (PEPFAR). The project is framed as a practical pilot that would be carried out in real-world HIV care and treatment settings, with an emphasis on generating usable evidence and documentation that can inform future service delivery decisions.
At the core of the announcement is a specific service delivery question: whether a "single-visit approach" to cervical cancer screening and immediate management is safe, acceptable, and feasible for HIV-positive women receiving HIV services in Ethiopia. The approach described relies on visual inspection with acetic acid (VIA) as the screening method. Women who screen positive would receive same-day cryotherapy treatment when appropriate, or be referred for additional evaluation and care when cryotherapy is not indicated. The single-visit design matters because it aims to reduce loss to follow-up, which can be a major barrier in screening programs that require women to return for results and treatment on later dates.
The funding mechanism is a cooperative agreement, which generally indicates substantial involvement by CDC in the funded project compared to a standard grant. The activity category is health, and the CFDA number listed is 93.067 (Global AIDS), aligning it directly with HIV-related program priorities and systems. The intention is not simply to provide clinical services, but to pilot, document, and assess implementation in a way that answers operational questions about integrating cervical cancer prevention into HIV platforms.
Financially, CDC anticipated funding approximately one award. The expected award amount is up to $493,777 (the stated award ceiling), with a minimum award floor of $300,000. The announcement also lists an estimated total funding amount of $2,468,885, which appears to reflect the broader funding projection for the announcement context, while the specific "approximately $493,777" figure is tied to the anticipated single award described. No cost sharing or matching requirement is indicated, which reduces financial barriers for applicants.
Eligibility is described as unrestricted, meaning the opportunity is open to any type of entity, subject to any clarifications that may appear in the full announcement under the eligibility section. This typically allows a wide range of applicants such as domestic or international organizations, academic institutions, nongovernmental organizations, and other entities capable of implementing and evaluating the proposed pilot in Ethiopian HIV care settings, provided they meet the requirements laid out in the full funding announcement.
Key dates included in the posting indicate that the opportunity was posted and created on March 30, 2009. Applications were due by May 28, 2009 at 5:00 PM Eastern Time. The archive date is June 27, 2009, and the estimated funding date was prior to September 30, 2009, suggesting an intent to make an award within the U.S. government fiscal year timeline. Applicants were directed to the full details via Grants.gov, and a CDC Procurement and Grants Office (PGO TIMS) contact was provided for those who had difficulty accessing the full announcement electronically, including a phone number (770-488-2700) and a general email contact.
Overall, the opportunity is best understood as a targeted implementation and learning project: testing a same-day VIA-and-treat model (with cryotherapy or referral) for HIV-positive women in Ethiopia, documenting how well it works in practice, and producing evidence on safety, acceptability to patients and providers, and feasibility within HIV treatment settings where integration could improve uptake and reduce cervical cancer burden in a high-risk population.
Frequently Asked Questions (FAQs)
What is the funding opportunity number for this grant?
The funding opportunity number is CDC RFA PS09-999.
Which U.S. agency is offering this opportunity?
This opportunity is offered by the Centers for Disease Control and Prevention (CDC).
What type of award is this?
This is a cooperative agreement, which generally means CDC expects substantial involvement in the funded project compared with a standard grant.
What is the main goal of this cooperative agreement?
The goal is to reduce cervical cancer risk among women living with HIV in the Federal Democratic Republic of Ethiopia by piloting and assessing a practical service delivery approach in real-world HIV care and treatment settings.
How does this opportunity relate to PEPFAR?
The project is supported under the President's Emergency Plan for AIDS Relief (PEPFAR).
What is the central question the project is trying to answer?
The project is designed to determine whether a "single-visit approach" to cervical cancer screening and immediate management is safe, acceptable, and feasible for HIV-positive women receiving HIV services in Ethiopia.
What does "single-visit approach" mean in this announcement?
It refers to a model in which screening and, when appropriate, treatment happen on the same day rather than requiring women to return later for results and treatment.
Why is the single-visit design important?
The single-visit design aims to reduce loss to follow-up, which can be a major barrier in screening programs that require multiple visits.
What screening method is specified in the opportunity?
The screening method described is visual inspection with acetic acid (VIA).
What happens if a woman screens positive using VIA?
Women who screen positive would receive same-day cryotherapy treatment when appropriate, or be referred for additional evaluation and care when cryotherapy is not indicated.
Does the opportunity focus only on providing clinical services?
No. The stated intention is not simply to provide clinical services, but to pilot, document, and assess implementation so the project generates usable evidence and documentation to inform future service delivery decisions.
Where is the pilot intended to be carried out?
The pilot is framed to be carried out in real-world HIV care and treatment settings in Ethiopia.
Who is the target population for the pilot?
The focus is on women living with HIV (HIV-positive women) receiving HIV services in Ethiopia.
What activity category is listed for this opportunity?
The activity category is health.
What CFDA number is associated with this funding?
The CFDA number listed is 93.067 (Global AIDS).
How many awards did CDC anticipate making?
CDC anticipated funding approximately one award.
What is the expected award amount?
The expected award amount is up to $493,777 (the stated award ceiling).
Is there a minimum award amount listed?
Yes. The minimum award floor listed is $300,000.
What is the estimated total funding amount mentioned, and how does it relate to the single award?
The announcement lists an estimated total funding amount of $2,468,885, while also stating an expected award of approximately $493,777 for the anticipated single award. Based on the information provided, the larger figure appears to reflect a broader funding projection for the announcement context, while the approximately $493,777 figure is tied to the anticipated single award described.
Is cost sharing or a match required?
No cost sharing or matching requirement is indicated.
Who is eligible to apply?
Eligibility is described as unrestricted, meaning the opportunity is open to any type of entity, subject to any clarifications in the full announcement's eligibility section.
When was the opportunity posted and created?
The posting and creation date is March 30, 2009.
When were applications due?
Applications were due by May 28, 2009 at 5:00 PM Eastern Time.
When was the opportunity archived?
The archive date is June 27, 2009.
When was funding expected to be awarded?
The estimated funding date was prior to September 30, 2009.
Where were applicants directed to find full details and apply?
Applicants were directed to the full details via Grants.gov.
What should someone do if they have difficulty accessing the full announcement electronically?
The announcement indicates that a CDC Procurement and Grants Office (PGO TIMS) contact was provided for those who had difficulty accessing the full announcement electronically, including a phone number (770-488-2700) and a general email contact.
What kind of evidence is the project expected to produce?
The project is framed as a practical pilot emphasizing usable evidence and documentation about implementation, including evidence related to safety, acceptability to patients and providers, and feasibility within HIV treatment settings.
What is the broader purpose of generating documentation and evidence in this pilot?
The documentation and evidence are intended to inform future service delivery decisions about integrating cervical cancer prevention into HIV service platforms in Ethiopia.
Browse more business programs for Women in Business
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Mathematics for Analysis of Petascale Data
Previous opportunity: Strengthening Pre service and In service HIV Training in the Republic of Kenya under the President s Emergency Plan for AIDS Relief
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS09 999
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS09 999) also looked into and applied for these:
| Funding Opportunity |
|---|
| Assistance to Develop and Implement a Behavior Change Information and Communications (BCIC) Approach for the Government of Botswana s (GOB) Newly Adopted Safe Male Circumcision Strategy under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 933 Funding Number: CDC RFA PS09 933 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Technical Assistance for In Service Training of Health Care Providers in Botswana in Management of HIV/AIDS and HIV/TB Co infection in the Republic of Botswana under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 934 Funding Number: CDC RFA PS09 934 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,166,350 |
| Support for Training of HIV Health Care Providers in the Republic of Botswana under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 938 Funding Number: CDC RFA PS09 938 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,300,000 |
| Rapid Strengthening and Expansion of Integrated Social Services for People Living with HIV/AIDS (PLWHA) in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 941 Funding Number: CDC RFA PS09 941 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Technical Assistance for the Support of Laboratory and Other Activities in Portuguese Speaking Countries in Africa under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 944 Funding Number: CDC RFA PS09 944 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,600,000 |
| Hinterland Initiative Expanding HIV/AIDS Services to Indigenous Amerindian Communities of Regions 1 and 9 Building Partnerships and Strengthening Coordinating Capacity under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 948 Funding Number: CDC RFA PS09 948 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Implementation and Strengthening of Laboratory Health Systems in PEPFAR Countries through Quality Management Systems and Laboratory Accreditation under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 949 Funding Number: CDC RFA PS09 949 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Expansion of HIV/AIDS, STI and TB Laboratory Activities in the Namibia Institute of Pathology (NIP), Ltd. under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 955 Funding Number: CDC RFA PS09 955 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,144,093 |
| Increasing Public Health Workforce Capacity to Implement and Deliver Laboratory Services and Public Health Interventions in the Dominican Republic under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 959 Funding Number: CDC RFA PS09 959 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Supporting the Implementation and Expansion of High Quality HIV Prevention, Care and Treatment Activities at Facility and Community Level in the Republic of Kenya under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 962 Funding Number: CDC RFA PS09 962 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $275,000,000 |
| Strengthening HIV/AIDS, STI and TB Prevention, Care and Treatment Activities within the Addis Ababa University Community, Ministry of Health (MoH) and Selected Regions in Ethiopia under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 9101 Funding Number: CDC RFA PS09 9101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $367,688 |
| Prevention in Rural and Urban Hotspots for Most at Risk Populations (MARPs) including Students, Mobile Merchants, Commercial Sex Workers, and Daily Laborers in Amhara Region of the Federal Democratic Republic of Ethiopia under the President s Emergen Apply for CDC RFA PS09 9102 Funding Number: CDC RFA PS09 9102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Rapid Scale Up of HIV/AIDS Care and Treatment Services in the Kingdom of Swaziland under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 913 Funding Number: CDC RFA PS09 913 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Achievement and Maintenance of Universal Coverage with Long Lasting Insecticide Treated Apply for USAID TANZANIA 09 002 RFA Funding Number: USAID TANZANIA 09 002 RFA Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $40,000,000 |
| Capacity Building Assistance to Support Sustainable HIV/AIDS Integrated Laboratory Program Development under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 914 Funding Number: CDC RFA PS09 914 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $15,000,000 |
| Strengthening the State of Tamil Nadu Response to HIV/AIDS in Chennai, India through the Tamil Nadu State AIDS Control Society (TNSACS) under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 918 Funding Number: CDC RFA PS09 918 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Improving Diagnosis and Preventing the Spread of Tuberculosis in HIV/AIDS Infected People in the Kingdom of Cambodia under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 919 Funding Number: CDC RFA PS09 919 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Expansion of HIV Prevention Counseling, Psychosocial Support and Outreach Services in Botswana under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 926 Funding Number: CDC RFA PS09 926 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,825,000 |
| Technical Assistance for Injection Safety in the Republic of Botswana under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 927 Funding Number: CDC RFA PS09 927 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Expansion of Safe Male Circumcision Services to Prevent HIV in Botswana under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 928 Funding Number: CDC RFA PS09 928 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,953,063 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS09 999", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.